Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for MCK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 1.024B
March 31, 2026 425.00M
December 31, 2025 -269.00M
September 30, 2025 -24.00M
June 30, 2025 -3.564B
March 31, 2025 -224.00M
December 31, 2024 -136.00M
September 30, 2024 -286.00M
June 30, 2024 -87.00M
March 31, 2024 -577.00M
December 31, 2023 -180.00M
September 30, 2023 -166.00M
June 30, 2023 -149.00M
March 31, 2023 -244.00M
December 31, 2022 -414.00M
September 30, 2022 77.00M
June 30, 2022 39.00M
March 31, 2022 183.00M
December 31, 2021 -115.00M
September 30, 2021 -58.00M
June 30, 2021 -99.00M
March 31, 2021 -205.00M
December 31, 2020 68.00M
September 30, 2020 -148.00M
June 30, 2020 -130.00M
Date Value
March 31, 2020 -170.00M
December 31, 2019 -124.00M
September 30, 2019 -156.00M
June 30, 2019 -129.00M
March 31, 2019 -230.00M
December 31, 2018 -168.00M
September 30, 2018 -108.00M
June 30, 2018 -875.00M
March 31, 2018 -1.039B
December 31, 2017 -87.00M
September 30, 2017 -267.00M
June 30, 2017 -129.00M
March 31, 2017 -177.00M
December 31, 2016 -2.273B
September 30, 2016 -192.00M
June 30, 2016 -1.154B
March 31, 2016 -1.329B
December 31, 2015 -159.00M
September 30, 2015 -52.00M
June 30, 2015 -17.00M
March 31, 2015 -238.00M
December 31, 2014 -132.00M
September 30, 2014 -195.00M
June 30, 2014 -112.00M
March 31, 2014 -4.624B

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -240.15M
Cardinal Health, Inc. -284.00M
Henry Schein, Inc. -13.00M
CVS Health Corp. -1.884B
Accendra Health, Inc. -31.24M